Bayer Sells Stake in Contraceptives Business to Apollo

The sale is part of Bayer's strategy to bolster its balance sheet after facing significant legal challenges related to its Roundup weedkiller product. S1S2

• Bayer sold a minority stake in its contraceptives business to Apollo Global Management. S1S2
• The transaction is valued at €3 billion, equivalent to $3.4 billion. S2
• Funds from the sale will be used to address litigation costs associated with Roundup. S1S2
• This sale is part of Bayer's broader financial strategy to improve its balance sheet. S1
• The deal highlights the ongoing financial pressures faced by Bayer due to legal issues. S2
• Apollo Global Management is a prominent investment firm involved in the transaction. S2
• Bayer's contraceptives business is a significant part of its overall portfolio. S1
• The sale reflects Bayer's efforts to navigate its financial challenges effectively. S1S2

• The sale helps Bayer manage its financial obligations amid costly litigation. S1S2
• Strengthening the balance sheet may improve Bayer's market position and investor confidence. S1

• Monitor Bayer's financial performance post-sale and its impact on litigation costs. S1S2
• Watch for any further strategic moves by Bayer in response to ongoing legal challenges. S1